REVERAGEN
Live / Registered — Registered and renewed (as of 31 Jul 2025)
What this means for you
Registered since 14 Apr 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Apr 2025).
Record
- Serial number
- 86386229
- Registration number
- 4720198
- Mark type
- Stylized text
- Filed
- 05 Sept 2014
- Published for opposition
- 27 Jan 2015
- Registered
- 14 Apr 2015
- Next maintenance due
- 14 Apr 2025
- Attorney of record
- Tim Burgdorf
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- ReveraGen Biopharma, Inc., Rockville, MD, US
- ReveraGen Biopharma, Inc., Rockville, MD, US
- ReveraGen Biopharma, Inc., Rockville, MD, US
Prosecution history
- 31 Jul 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 31 Jul 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 31 Jul 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 31 Jul 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Mar 2025 — TEAS SECTION 8 & 9 RECEIVED
- 14 Apr 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 09 Aug 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 09 Aug 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 09 Aug 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Apr 2021 — TEAS SECTION 8 & 15 RECEIVED
- 14 Apr 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Apr 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Oct 2016 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Apr 2015 — REGISTERED-PRINCIPAL REGISTER
- 27 Jan 2015 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED